Evidence map›Paper›PMID 34996362›Full record

ArticleBMC medical research methodology2022

Oncologic patients' misconceptions may impede enrollment into clinical trials: a cross-sectional study.

Nethanel Asher, Ari Raphael, Ido Wolf, Sharon Pelles, Ravit Geva

Open access · goldAbstract read
In one paragraph

Article in BMC medical research methodology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Exploring patient-reported barriers to participating in proton therapy clinical trials.Technical innovations & patient support in radiation oncology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Nethanel Asher *The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel Hashomer, Israel.
Ari Raphael *Sackler Faculty of Medicine Tel Aviv University Tel Aviv, Tel Aviv, Israel.
Ido WolfSackler Faculty of Medicine Tel Aviv University Tel Aviv, Tel Aviv, Israel.
Sharon PellesSackler Faculty of Medicine Tel Aviv University Tel Aviv, Tel Aviv, Israel.
Ravit GevaSackler Faculty of Medicine Tel Aviv University Tel Aviv, Tel Aviv, Israel. ravitg@tlvmc.gov.il.ORCID 0000-0002-5380-4948
Tel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClinical trials are an essential source for advances in oncologic care, yet the enrollment rate is only 2-4%. Patients' reluctance to participate is an important barrier. This study evaluates patients' level of understanding and attitudes towards clinical trials.

methodsThis cross-sectional study was conducted in the oncology department and day care unit at the oncology division Tel Aviv Sourasky Medical Center, Israel. From January 2015 to September 2016. Two-hundred patients' currently receiving active anti-cancer therapy at a large tertiary hospital completed an anonymous questionnaire comprised of demographic information, past experience in clinical research and basic knowledge on clinical trials.

resultsThe majority of respondents did not meet the minimum knowledge level criteria. In those who replied they would decline to participate in a clinical trial, concern were related to potential assignment to the placebo arm, provision of informed consent and trust issues with their oncologist. Those with sufficient knowledge were significantly more interested in participating. Patients with past experience in clinical trials had a higher level of academic education, were less religious, had a better understanding of medical research and were inclined to participate in future research.

conclusionsMisperceptions of clinical trials may contribute substantially to the unwillingness to participate in them.

Indexed as

Clinical Trials as TopicNeoplasmsPatient ParticipationCross-Sectional StudiesHumansInformed ConsentSurveys and QuestionnairesAccrual strategiesCancer clinical trialCancer patient educationCancer patient misconceptionPatient knowledge

Identifiers

PMID34996362
PMCPMC8742439
OpenAlexW4205102562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.